AliveCor, a startup developing algorithms that detect atrial fibrillation, bradycardia, tachycardia, and other health issues from heart rate readings, today raised $65 million in funding. The company ...

AliveCor announced today that it has received CE mark in Europe for its Kardia 12L electrocardiogram (ECG) system.

Cardio-focused digital health company AliveCor landed FDA clearance for its new suite of interpretive ECG algorithms, dubbed the Kardia AI V2. This news comes just days after the company announced a ...

Pharma giant AstraZeneca is teaming up with AliveCor, maker of artificial intelligence-enabled personal ECG devices, in an effort to study new ways of managing cardio, renal and metabolic issues. The ...

On March 7, 2025, the Federal Circuit issued a decision resolving the ongoing patent litigation between AliveCor and Apple concerning methods of cardiac monitoring purportedly employed in certain of ...

Explore the top mobile IV therapy companies boosting immune health on demand, with standout services, expert care and innovative delivery across the U.S. The Kardia Pro app is for clinical use. But ...

SAN FRANCISCO--(BUSINESS WIRE)--AliveCor, Inc., a premier digital health company, announced today that its Heart Monitor is now available for the iPhone 5, joining the current models for the iPhone 4 ...

AliveCor’s Kardia 12L, a pocket-sized AI ECG system, has received CE Mark for launch in France, Germany, Italy, Spain, and ...

Earlier this year, AliveCor, Inc., a medical device and AI company producing electrocardiogram (ECG) hardware and software for consumer mobile devices, succeeded in convincing an International Trade ...

Throughout its storied history, Apple has been no stranger to litigation. While many articles about the Cupertino, California-based tech giant’s legal woes are currently being published given the ...

Device maker copied wearable heart-monitoring technology -Apple AliveCor said Apple infringed its heart-monitoring patents (Reuters) - Apple Inc sued medical-device maker AliveCor Inc in San Francisco ...

The U.S. Food and Drug Administration has granted AliveCor the designation of “breakthrough device” for its ability to detect a rare but dangerous blood condition called hyperkalemia without taking ...